Daniel Goodman
A synthetic immunologist and computational biologist working at the intersection of genome engineering, immune cell therapy, and genetic design using generative models. Working at UCSF with Kole Roybal & Alex Marson on the next generation of T cell therapies for cancer and autoimmune disease. MIT Ph.D. alum from George Church's lab.
UCSF
Thursday
May 08
Designing Cellular Medicines: Using High-Throughput Experiments and AI Approaches to Program Cells to Cure Disease
1:30 PM
-
2:15 PM
We now live in a world where genetically engineered cells are circulating people's bodies and warding off cancer. But the first approved cell-based medicines—such as CAR-T therapy—are just the beginning. In this session, we'll explore the next generation of programmable cellular medicines.
